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INTRODUCTION
In Denmark, between 2003 and 2015, there were ap-
proximately 16,400 bariatric procedures performed.1,2 
Many patients who have bariatric surgery develop excess 
skin as a consequence of massive weight loss. Body con-
touring with removal of excess skin is often needed to fully 
restore a patient’s body image and health-related quality 
of life (HR-QOL).3
To be able to measure change in HR-QOL along the 
patient weight loss journey, a well-developed patient-re-
ported outcome (PRO) instrument is needed. Previous lit-
erature concerning PRO instruments for bariatric and/or 
body-contouring surgery has identified the need for a new 
and comprehensive PRO instrument.4–9 In a recent review, 
Gilmartin et al.10 also call for a new PRO instrument de-
signed for the patient group and point to the newly pub-
lished BODY-Q as a possible candidate tool.11
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The Moorehead-Ardelt Quality of Life Questionnaire12 
is the PRO instrument that is included in the Danish Bar-
iatric Surgery Database to document change in HR-QOL 
for Danish patients having bariatric and body-contouring 
surgery.2 We have previously described the limitations of 
the Moorehead-Ardelt Quality of Life Questionnaire in 
the Danish system and the need for a more appropriate 
PRO instrument for use in monitoring outcomes follow-
ing bariatric and body contouring surgery.1,13
The BODY-Q is a new PRO instrument designed for 
weight loss and body-contouring treatments. The BODY-Q 
was specifically designed to measure changes in important 
patient outcomes over the entire patient journey, from 
obesity to post-body contouring surgery.7,11 The BODY-Q 
consists of 18 independently functioning scales grouped 
into 3 main domains: appearance, HR-QOL, and experi-
ence of health-care. There is also an obesity-specific symp-
tom checklist; however, it is important to notice that the 
symptom checklist is not scored as a scale, but rather as 
a set of independent items measuring symptoms. Inter-
nationally recommended guidelines for item generation, 
item reduction, and psychometric evaluation were fol-
lowed in the development of the BODY-Q.14–19 A strength 
of the BODY-Q is the use of Rasch Measurement Theory 
(RMT), which contributes to developing interval level 
measurement scales.20,21
The BODY-Q was developed and field-tested in the 
United States, Canada, and United Kingdom, which limit 
its immediate generalization to other non–English-speak-
ing countries. When adapting a PRO instrument for use in 
another country and/or culture, it is essential to start with 
an appropriate translation and linguistic validation study, 
followed by psychometric validation.22,23 Due to the lack of 
a comprehensive and robust PRO instrument for patients 
who undergo bariatric and body-contouring treatments in 
Denmark, we translated and evaluated the BODY-Q in a 
large sample of Danish patients having bariatric and/or 
body contouring. In this article, we describe the findings 
from the Danish field-test and psychometric validation 
study.
METHODS AND MATERIALS
The study was approved by the Danish Data Protection 
Agency before commencement. Ethics approval was ap-
plied for at the Regional Scientific Ethical Committee for 
Southern Denmark, who found no reason for approval, as 
our study was an interview and questionnaire survey.
The process consisted of 3 stages described further un-
derneath: translation and linguistic validation, field-test, 
and data analysis.
Stage I: Translation, Cultural Adaption and Linguistic 
Validation
The translation and linguistic validation was per-
formed according to recommendations of the Interna-
tional Society for Pharmacoeconomics and Outcomes 
Research22 and the World Health Organization23 and is 
described in detail elsewhere.13 Briefly, 2 independent for-
ward translations were produced by a professional trans-
lator and a clinician, both of whom had Danish as their 
mother tongue and were fluent in English. The harmo-
nized forward translation was provided to a professional 
translator who had English as their mother tongue and 
was fluent in Danish who performed a back translation. 
The back translation was then compared with the original 
English version. Discrepancies were discussed with the in-
strument’s developers and revised in an iterative manner 
until a final version was produced. An expert panel meet-
ing was held to ensure the BODY-Q included all clinically 
relevant issues from the perspective of Danish clinicians. 
We then conducted 2 rounds of cognitive interviews with 
a total of 22 patients. These interviews were used to deter-
mine if any aspect of the BODY-Q was poorly worded or 
asked about issues not relevant to patients in Denmark. 
Feedback from patients and proof reading by 2 clinicians 
was used to revise and finalize the Danish version of the 
BODY-Q.
Stage II: Field-Test
The BODY-Q and relevant demographic and clinical 
questions were developed into an online REDCap (i.e., 
Research Electronic Data Capture) survey (http://proj-
ect-redcap.org). Researchers at Odense University Hos-
pital are granted access to REDCap through the Odense 
Patient data Explorative Network.24 In the period June 
2015 to June 2016, 4 groups of patients were recruited 
from Odense University Hospital (Department of Endo-
crinology and Department of Plastic Surgery) and Hospi-
tal of Southwest Jutland (Bariatric Center/Department of 
Endocrinology and Department of Plastic Surgery):
 1. Prebariatric surgery: This group included patients 
who were referred for obesity treatment and/or bar-
iatric surgery.
 2. Postbariatric surgery: This group included patients 
who had bariatric surgery. Participants were asked to 
complete the BODY-Q survey at the following inter-
vals: 4–5, 12, and 24 months postsurgery.
 3. Prebody contouring: Patients referred for body-con-
touring surgery following massive weight loss.
 4. Postbody contouring: Patients who had undergone 
body contouring following massive weight loss. Par-
ticipants had undergone at least one of the following 
procedures: abdominoplasty, upper arm lift, thigh lift, 
buttocks lift, and/or breast lift. Patients were asked to 
complete the BODY-Q survey 3 and 12 months after 
body contouring.
Patients scheduled for an outpatient appointment 
were sent an information letter about the study, with a link 
to access and complete the BODY-Q survey in REDCap. 
At the Hospital of Southwest Jutland, patients were sent 
mobile text reminders before their scheduled outpatient 
clinic appointment. At both hospitals, patients attending 
an outpatient appointment who had not completed the 
BODY-Q survey before their appointment were invited to 
do so using a tablet in the outpatient clinic. Patients were, 
according to agreement with the Danish Data Protection 
Agency, asked electronically to provide informed consent 
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for their data being used for research. Exclusion criteria 
were inability to speak or understand Danish.
Stage III: Data Analysis
Descriptive data were analyzed using SPSS software 
(IBM SPSS Statistics, version 22.0, IBM Corp). The psy-
chometric properties of the Danish BODY-Q were ana-
lyzed using RMT analysis to determine if the scales meet 
the requirements of the Rasch model. Analysis was per-
formed using RUMM 2030 software (RUMM version 
2030, 1998-14 RUMM Laboratory Pty Ltd.; http://www.
rummlab.com.au).
RMT Analysis
RMT is a psychometric method that can provide in-
sights into strengths and limitations of a PRO scale.20 We 
performed the same set of analyses as reported in the 
BODY-Q development and psychometric validation ar-
ticle,11 to compare the findings of the Danish and original 
versions. The psychometric parameters that were evalu-
ated included the following:
 1.  Category threshold order: For each BODY-Q scales, we 
examined thresholds between item response options 
(e.g., definitely disagree, somewhat disagree, some-
what agree, definitely agree). Disordered thresholds 
can occur as a consequence of unclear definitions, 
the number of response options, and underutiliza-
tion.25 The measurement probabilities of a PRO scale 
can be compromised if response options are not used 
in an orderly fashion.26
 2.  Measurement precision: For each scale, we estimated 
the measurement precision by the person separation 
index (PSI). PSI measures the error, that is, the high-
er PSI, the higher reliability.27 PSI can be compared 
with the Cronbach α value.28
 3.  Item fit statistics: We examined 3 indicators of item fit 
to the Rasch model: (1) Log residuals (item–person 
interaction); (2) χ2 values (item–trait interaction); 
and (3) Item characteristic curves. Results were in-
terpreted fit statistics together and in relation to the 
clinical importance of each item. Fit residuals should 
be between −2.5 and +2.5, and χ2 values should be 
nonsignificant after Bonferroni adjustment.
 4.  Dependency: We examined the residual correlations 
between items. Correlation between pairs of items 
should be lower than 0.30. High residual correlations 
can artificially inflate scale reliability. If values were 
≥ 0.30, we performed subtest analysis to investigate 
the impact they had on the PSI.29
 5.  Targeting: Targeting examines the extent to which 
the items that form a scale measure the construct that 
is experienced by the study population. For targeting, 
we examined the person and item locations.
 6. Differential Item Functioning: Differential item func-
tioning (DIF) refers to the stability of an instrument, 
that is, whether an item is responded to differently by 
subgroups within a population. To examine DIF, the 
BODY-Q dataset from the original study sample (Can-
ada, the United States, and the United Kingdom) was 
included alongside the Danish dataset and analyzed 
in RUMM2030. We examined DIF by country to deter-
mine if the Danish sample differed from the original 
study sample. Items with potential DIF were located by 
significant chi-square values after Bonferroni adjust-
ment. If DIF was located, the sample was split by DIF 
and then looked at to see if it made any difference.
 7. Correlation to original scoring: To examine whether 
the original BODY-Q scoring key can be used, we cor-
related the logit scores for each scale’s set of items 
with for the Danish study sample and original study 
sample (Canada, the United States, and the United 
Kingdom).
RESULTS
A total of 495 patients completed the Danish BODY-Q 
field test between 1 and 4 times. Including data for patients 
who filled out the experience of care scales twice (i.e., once 
in relation to their experience of care in weight loss clinic 
and once for their experience in relation to their experi-
ence of care in the bariatric surgery clinic), there were a 
total of 681 assessments. Characteristics for each patient 
group are outlined in Table 1. The overall response rate 
was 76%. For the bariatric group, the response rate was 
84%, and for the body-contouring group, it was 72%. Six-
teen percentage of responses were prebariatric surgery, 
33% were postbariatric surgery, 34% were prebody con-
touring, and 17% were postbody contouring. The percent-
age of missing responses at item level was 1% in total.
Overall, the RMT analysis provided broad support for 
the reliability and validity of the Danish version of the 
BODY-Q scales. Appendix 1 provides the detailed RMT 
statistics for the 138 BODY-Q items, organized by scale, 
and within scale, by the item order based on the Rasch 
model in the original study (Appendix, Supplemental 
Digital Content 1, http://links.lww.com/PRSGO/A572). For 
item fit statistics, item fit was outside the criteria of ˗2.5 to 
+2.5 for 34 of 138 items, and of these, 21 had a significant 
chi-square P value after Bonferroni adjustment.
Most items (128 of 138) had ordered thresholds. Of 
the 10 disordered items, all except one item in the Physi-
cal Function scale [Bending over (e.g., to tie your shoes)] 
was in a patient experience scale, including the Doctor 
scale (item 100, 101, 102, 103, 105, and 106) and Informa-
tion scale (item 129, 130, and 132).
Table 2 provides the scale performance findings. In 
terms of scale reliability, Cronbach α values were ≥ 0.90 
for all scales. Appearance scales and QOL scales evidence 
high reliability, with all PSI values (with and without ex-
tremes) ≥ 0.74 [exception Hips/Outer Thighs = 0.37 
(without extremes)]. The PSI values for the patient ex-
perience scales were lower and ranged from 0.32 to 0.70 
(with extremes) and 0.69–0.86 (without extremes).
Item residual correlations were above 0.30 (range, 
0.31–0.52) for 10 pairs of items within 8 scales. In sub-
test analysis, the correlated items were found to have mi-
nor influence on scale reliability with a difference in PSI 
 value ≤ 0.73.
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Figure 1 shows examples of the person-item threshold 
distribution for the social (1a) and psychological (1b) 
function scales. Person locations are shown in the up-
per half, whereas item locations are located in the lower 
half. The figures confirm that the scales are able to pro-
vide information for all levels of the constructs measured 
(Figs. 1, 2).
DIF was examined by comparing the original study 
population (Canada, the United States, and the United 
Kingdom) with the Danish study population. The original 
study sample consisted of 965 assessments provided by 734 
participants. We adjusted the sample size to 500 for the 
analysis, and DIF was significant for 27 of 138 items. How-
ever, when these items were split on the variable (country) 
with DIF, and the new person locations were correlated 
with the original person locations, DIF was found to have 
a negligible impact. For 17 of 18 scales, the Pearson corre-
lation was ≥ 0.99 for the calculated score. The correlation 
for the remaining scale (office staff) was 0.97. Our find-
ings confirm that the original scoring key can be used in 
the Danish version.
The physical symptom checklist was completed 572 
times. Table 3 shows frequencies for each symptom. The 
most frequent symptom reported to be there all the time 
was joint pain followed by short of breath with mild exer-
cise and back pain.




PSI with  
Extremes
PSI No  
Extremes Chi-Square DF P F/C (%)
Crohnbachs 
Alpha
Body 568 0.92 0.92 181.23 90 0.000 7/1 0.95
Arms 565 0.91 0.90 149.49 56 0.000 14/3 0.95
Abdomen 567 0.92 0.93 103.36 42 0.000 33/5 0.98
Back 558 0.88 0.83 76.34 20 0.000 15/12 0.96
Buttocks 562 0.90 0.83 34.43 30 0.264 17/10 0.95
Hips and outer thighs 563 0.92 0.37 26.20 30 0.665 20/2 0.97
Inner thighs 561 0.79 0.80 48.18 20 0.000 43/3 0.96
Skin 481 0.85 0.86 48.55 35 0.064 29/3 0.95
Scars 112 0.86 0.88 46.21 20 0.001 1/26 0.95
Body image 566 0.90 0.90 67.63 49 0.040 23/1 0.96
Physical 450 0.80 0.82 57.57 35 0.010 2/24 0.92
Psychological 567 0.92 0.92 157.90 90 0.000 3/7 0.95
Sexual 559 0.80 0.74 70.35 40 0.002 16/5 0.90
Social 567 0.90 0.90 158.97 90 0.000 1/10 0.94
Doctor 342 0.32 0.69 18.41 20 0.561 0/56 0.95
Medical team 342 0.70 0.86 29.27 20 0.083 0/49 0.96
Office staff 329 0.47 0.86 21.18 20 0.387 1/70 0.97
Information 227 0.68 0.74 30.71 20 0.059 1/33 0.92
DF, degree of freedom; P, probability.
Table 1. Characteristics of the Field-Test Sample, Divided by Classification of Time of Journey
Characteristics 








Age (N = 679)     
  Mean 43 42 42 45
  Range (21–63) (23–65) (17–66) (23–75)
Gender (N = 680) (%)     
  Female 74 (67) 164 (73) 193 (84) 95 (83)
  Male 36 (33) 62 (27) 37 (16) 19 (17)
BMI (N = 670)     
  Mean 45 32 28 27
  Range (32–68) (20–63) (21–67) (20–36)
Comorbidity (N = 674) (%)     
  Yes 77 (71) 100 (45) 67 (29) 35 (31)
  No 32 (29) 124 (55) 161 (71) 78 (69)
Marital status (N = 673) (%)     
  Married 57 (52) 122 (54) 88 (39) 46 (41)
  Living together 16 (15) 40 (18) 63 (28) 33 (29)
  Widow 1 (1) 0 (0) 4 (2) 3 (3)
  Separated 1 (1) 2 (1) 2 (1) 2 (2)
  Divorced 10 (9) 16 (7) 26 (11) 11 (10)
  Single, never married 25 (23) 44 (20) 44 (19) 17 (15)
Education (N = 679) (%)     
  None 1 (1) 8 (4) 6 (3) 2 (2)
  Primary school 25 (23) 44 (19) 37 (16) 18 (16)
  Youth, vocational or secondary education 30 (27) 56 (25) 52 (23) 23 (20)
  Short higher education 17 (15) 46 (20) 58 (25) 24 (21)
  Medium higher education 32 (29) 62 (27) 65 (28) 42 (37)
  Long higher education 5 (5) 8 (4) 12 (5) 4 (4)
  PhD or master 0 (0) 2 (1) 0 (0) 0 (0)
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Fig. 1. Person-item threshold distribution for the social wellbeing scale.
Fig. 2. Person-item threshold distribution for the psychological wellbeing scale.
Table 3. Physical Symptom Frequency, Total Number (%) of Assessments
Symptom








Feeling tired during the day 58 (10) 140 (25) 215 (38) 39 (7)
Back pain 65 (11) 102 (18) 183 (32) 102 (18)
Joint pain 76 (13) 103 (18) 159 (28) 114 (20)
Leg pain or discomfort 46 (8) 102 (18) 156 (27) 147 (26)
Feeling of balance 27 (5) 57 (10) 194 (34) 174 (30)
Feeling weak 32 (6) 70 (12) 184 (32) 166 (29)
Short of breath with mild exercise 66 (12) 57 (10) 144 (25) 184 (32)
Swollen feet 40 (7) 58 (10) 152 (27) 202 (35)
Skin rash or infection 28 (5) 55 (10) 133 (23) 236 (41)
Too much perspiration 34 (6) 59 (10) 134 (23) 223 (39)
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DISCUSSION
The findings from our study provide broad support 
that the BODY-Q scales were acceptable, reliable, and 
valid in a Danish sample of bariatric and body-contouring 
patients. Based on the high response rate obtained for 
the online questionnaire survey30 and the low amount of 
missing data at item level (despite the large number of 
items tested), the BODY-Q was judged to be acceptable 
to patients.31 Patients completed all relevant scales, and a 
subset of patients even completed the experience of care 
scales twice. Elsewhere, we report that patients in the cog-
nitive interview phase of the translation process found the 
BODY-Q to be acceptable and that they were happy to fill 
it out and even relieved to have the opportunity to express 
how they felt.13
Within the RMT analysis, we observed some degree of 
misfit that we need to explore. Item fit was outside the cri-
teria for 34 of 138 items, and of these, 21 had a significant 
chi-square P value after Bonferroni adjustment. This only 
indicates that the observed responses to these items did not 
fit the Rasch model perfectly and that the misfit needs to 
be explored further. Previously a way to adjust for this was 
to exclude items; however, newer literature suggests that 
reasons should be explored and explained instead.32 As we 
found all items clinically relevant and important, we did 
not wish to exclude any items, and working through the 
affected items, we found good explanations to the statistical 
results. For example, 1 item was about the size of the body, 
which can be interpreted as both weight and subjective size. 
Another example was items asking about how toned spe-
cific parts of the body were. In Danish toned is not the most 
commonly used word, and as cognitive interviews suggest-
ed, it was translated into well trained instead, which might 
have influenced results.13 For thresholds, 128 of 138 items 
were ordered, indicating that response options worked as 
intended. Most disordered items were in the Doctor and 
Information scale, and when comparing the item order of 
these scales with the original BODY-Q item order, it was in 
broad agreement, which provides evidence of validity.
In terms of reliability, Cronbach α values were ≥ 0.90 
for all scales, and PSI values for all scales measuring ap-
pearance and quality of life concerns were high. Lower 
reliability was noted for the experience of care scales, 
which may warrant further examination. This finding is 
likely due to the finding that a high proportion of patients 
in the Danish sample reported scores at the ceiling on 
these 4 scales, particularly according to the doctor scale. 
Ceiling effects are important since they limit the ability to 
measure change and thereby measurement accuracy. The 
observed ceiling effects in the experience scales might 
be explained by cultural differences, a too small sample 
size—or simply reflection of patients’ satisfaction with 
treatment. These findings again could relate to the fact 
that the original sample is more heterogeneous, as partici-
pants were included from a range of weight loss and plastic 
surgery healthcare providers from 4 countries (England, 
Scotland, the United States, and Canada). Saiga et al.33,34 
recently published a Japanese translation and psychomet-
ric analysis of the BREAST-Q and also found ceiling  effect 
in the experience of care scales. They suggest that the 
ceiling effect could be associated with study design, which 
could also be the situation in our design, where patients 
were asked to fill out the BODY-Q as preparation for their 
follow-up visit in the outpatient clinic.
In item residual correlations, a cutoff point at 0.3 is often 
used, though it needs to be used carefully while the number 
of items potentially can influence. When looking at the scales 
and items, some amount of dependency must be expected; 
however, it has the potential to falsely inflate reliability. To 
investigate this further, we did a subtest analysis showing a 
difference in PSI value ≤ 0.73. If the reliability decreases in 
the subtest, it should be viewed as a more valid description 
of data.35 Based on this, the correlated items that we found 
should only have minor influence on scale reliability.
There are several limitations to our study. First, the 
sample was composed mainly of women, which was similar 
to the development sample and reflects the fact that more 
women come forward for bariatric and body-contouring 
surgery.36 Second, our sample does not include patients 
from all regions of Denmark. However, our study included 
4 different departments in 2 hospitals, and as Denmark is 
a small country with a total population of approximately 
5.7 million people,37 our sample must be considered rep-
resentative. Finally, we did not examine test–retest reliabil-
ity or responsiveness. These psychometric aspects could 
be the focus of future research.
CONCLUSIONS
Our study confirms that the Danish version of the 
BODY-Q is a valid and reliable PRO instrument for use 
in Danish bariatric and body-contouring patients. Further-
more, our study and analysis underlines the importance 
of doing a thorough translation and linguistic validation 
followed by field-testing and psychometric evaluation. Fi-
nally, we have demonstrated that the Danish version of 
the BODY-Q fulfills the need of a valid and reliable PRO 
instrument for the bariatric and body-contouring popula-
tion in Denmark.
Lotte Poulsen, MD
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